Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Nuwellis
(NASDAQ:NUWE)
Intraday
$0.249
-0.0255
[-9.29%]
After-Hours
$0.249
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$0.249
-0.0255
[-9.29%]
At close: May 10
$0.249
0
[0.00%]
After Hours: 7:56PM EDT
Get Report
Watch
Q1 2024 Earnings were released on Tue May 7th, before the market open
The most recent conference call was at 9:00 AM, 5 days ago
Click to view past webcast
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Nuwellis Stock (NASDAQ:NUWE)
Nuwellis Stock (NASDAQ: NUWE)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, May 09, 2024
Nuwellis Announces Purchase Agreement with 50 Hospital Network For Aquadex Ultrafiltration Therapy; Terms Not Disclosed
Benzinga Newsdesk
-
2 days ago
Wednesday, May 08, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
4 days ago
Tuesday, May 07, 2024
Nasdaq Moves Lower; Great Lakes Dredge & Dock Shares Surge Following Upbeat Earnings
Avi Kapoor
-
4 days ago
Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
-
4 days ago
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
4 days ago
Crude Oil Edges Lower; UBS Shares Jump After Q1 Earnings
Avi Kapoor
-
4 days ago
Nuwellis shares are trading higher after the company reported better-than-expected Q1 EPS results.
Benzinga Newsdesk
-
4 days ago
Dow Surges Over 50 Points; Disney Earnings Top Views
Avi Kapoor
-
4 days ago
Nuwellis Q1 2024 GAAP EPS $(0.60) Beats $(1.06) Estimate, Sales $1.90M Miss $2.00M Estimate
Benzinga Newsdesk
-
5 days ago
Friday, May 03, 2024
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
May 3, 2024, 12:31PM
Thursday, May 02, 2024
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
May 2, 2024, 12:31PM
Nuwellis shares are trading higher after the company announced that it received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent application related to its pediatric CRRT device branded Vivian.
Benzinga Newsdesk
-
May 2, 2024, 11:41AM
Nuwellis Receives USPTO Notice Of Patent Allowance For Innovative Pediatric CRRT Technology
Benzinga Newsdesk
-
May 2, 2024, 9:02AM
Friday, April 26, 2024
Dow Surges Over 200 Points; Microsoft Shares Gain Following Upbeat Earnings
Avi Kapoor
-
Apr 26, 2024, 2:50PM
Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
-
Apr 26, 2024, 1:56PM
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Apr 26, 2024, 12:31PM
S&P 500 Gains 1%; Exxon Mobil Posts Downbeat Earnings
Avi Kapoor
-
Apr 26, 2024, 12:06PM
Nuwellis shares are trading lower after the company announced pricing of a $2.7 million public offering.
Benzinga Newsdesk
-
Apr 26, 2024, 11:12AM
US Stocks Higher Following PCE Inflation Data; Nasdaq Jumps Over 200 Points
Avi Kapoor
-
Apr 26, 2024, 9:54AM
Nuwellis Announces Pricing Of $2.7M Public Offering Of 11.25M Shares Of Common Stock And Warrants To Purchase Up To An Aggregate Of 16.875M Shares Of Its Stock At A Combined Public Offering Price $0.24/Share
Benzinga Newsdesk
-
Apr 26, 2024, 9:19AM
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Apr 26, 2024, 8:06AM
Thursday, April 25, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
Apr 25, 2024, 8:06AM
Why Teradyne Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Apr 25, 2024, 6:12AM
Tuesday, April 23, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
-
Apr 23, 2024, 4:31PM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
-
Apr 23, 2024, 8:06AM
Why Hibbett Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Apr 23, 2024, 8:00AM
Monday, April 22, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Apr 22, 2024, 4:31PM
Nuwellis shares are trading higher after the company received a notice of allowance for its U.S. patent application 18/463,612 titled "Venous Blood Flow Stimulator For Extracorporeal Therapy"
Benzinga Newsdesk
-
Apr 22, 2024, 4:23PM
Nuwellis Has Received A Notice Of Allowance For Its U.S. Patent Application 18/463,612 Titled "Venous Blood Flow Stimulator For Extracorporeal Therapy"
Benzinga Newsdesk
-
Apr 22, 2024, 3:32PM
Tuesday, April 09, 2024
Nuwellis Launches Ultrafiltration Therapy Using Aquadex Smartflow System At Henry Ford Health
Benzinga Newsdesk
-
Apr 9, 2024, 9:04AM
Thursday, April 04, 2024
Nuwellis Filed U.S. Patent Application #20240108533: VENOUS BLOOD FLOW STIMULATOR FOR EXTRACORPOREAL THERAPY
Charles Gross
-
Apr 4, 2024, 3:53PM
Thursday, March 07, 2024
Nuwellis Announced Results From Two New Clinical Data Analyses From The AVOID-HF Trial Demonstrating Benefits Of Aquadex System For Heart Failure
Benzinga Newsdesk
-
Mar 7, 2024, 9:10AM
Tuesday, March 05, 2024
Nuwellis Q4 2023 GAAP EPS $(2.240) Misses $(1.390) Estimate, Sales $2.600M Beat $2.551M Estimate
Benzinga Newsdesk
-
Mar 5, 2024, 8:01AM
Earnings Scheduled For March 5, 2024
Benzinga Insights
-
Mar 5, 2024, 5:00AM
Monday, March 04, 2024
Earnings Preview For Nuwellis
Benzinga Insights
-
Mar 4, 2024, 1:03PM
Monday, February 26, 2024
Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
-
Feb 26, 2024, 1:57PM
Why Intuitive Machines Shares Are Trading Lower By Around 30%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Feb 26, 2024, 8:18AM
Thursday, February 22, 2024
Seastar Medical Holding Received FDA Approval Order For The Usage Of Selective Cytopheretic Device Pediatric In Children Weighing 10 Kilograms Or More With Acute Kidney Injury Due To Sepsis Or A Septic Condition Requiring Kidney Replacement Therapy
Benzinga Newsdesk
-
Feb 22, 2024, 7:56AM
Tuesday, February 20, 2024
Nuwellis To Announce Clinical Data At Technology And Heart Failure Therapeutics Conference
Benzinga Newsdesk
-
Feb 20, 2024, 8:48AM
Thursday, February 15, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Feb 15, 2024, 4:31PM
Monday, February 12, 2024
Overview Of Value Stocks In The Healthcare Sector
Benzinga Insights
-
Feb 12, 2024, 9:43AM
Why Amtech Systems Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Feb 12, 2024, 5:39AM
Tuesday, February 06, 2024
Nuwellis Published Data For Potential Of Aquadex SmartFlow System's Aquapheresis Therapy For End-Stage Liver Disease Patients With Fluid Overload
Benzinga Newsdesk
-
Feb 6, 2024, 9:06AM
Wednesday, January 31, 2024
Nuwellis Filed For Offering On Reasonable Best Efforts Basis Up To 16.3M Units, Up To 16.3 Mln Pre-funded Units
Charles Gross
-
Jan 31, 2024, 6:10AM
Thursday, January 25, 2024
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
Jan 25, 2024, 12:31PM
Friday, January 19, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Jan 19, 2024, 8:06AM
Tuesday, January 09, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
-
Jan 9, 2024, 4:31PM
Nuwellis Granted U.S. Patent #11865302: Extracorporeal blood filtering machine and methods
Charles Gross
-
Jan 9, 2024, 7:14AM
Thursday, January 04, 2024
Nuwellis shares are trading higher after the company received FDA clearance for an additional dual lumen extended length peripheral catheter.
Benzinga Newsdesk
-
Jan 4, 2024, 3:14PM
Nuwellis Receives FDA Clearance For An Additional Dual Lumen Extended Length Peripheral Catheter; Aquadex System Is Cleared By FDA For Use In Adults And Pediatric Patients Weighing 20 Kg (44 Lbs.) Or More
Benzinga Newsdesk
-
Jan 4, 2024, 3:11PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch